- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 125492, 11 pages
A Novel Bone Morphogenetic Protein 2 Mutant Mouse, , Displays Impaired Intracellular Handling in Skeletal Muscle
1Department of Microbiology and Molecular Biology, Brigham Young University, 775-A WIDB, Provo, UT 84602, USA
2Department of Nutrition, Dietetics, and Food Science, Brigham Young University, Provo, UT 84602, USA
3Department of Physiology and Developmental Biology, Brigham Young University, Provo, UT 84602, USA
Received 18 June 2013; Revised 12 October 2013; Accepted 29 October 2013
Academic Editor: Kunikazu Tsuji
Copyright © 2013 Laura C. Bridgewater et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. R. Urist, “Bone: formation by autoinduction,” Science, vol. 150, no. 698, pp. 893–899, 1965.
- J. M. Wozney, V. Rosen, A. J. Celeste et al., “Novel regulators of bone formation: molecular clones and activities,” Science, vol. 242, no. 4885, pp. 1528–1534, 1988.
- D. Chen, M. Zhao, and G. R. Mundy, “Bone morphogenetic proteins,” Growth Factors, vol. 22, no. 4, pp. 233–241, 2004.
- A. M. Goldstein, K. C. Brewer, A. M. Doyle, N. Nagy, and D. J. Roberts, “BMP signaling is necessary for neural crest cell migration and ganglion formation in the enteric nervous system,” Mechanisms of Development, vol. 122, no. 6, pp. 821–833, 2005.
- B. L. Hogan, “Bone morphogenetic proteins: multifunctional regulators of vertebrate development,” Genes and Development, vol. 10, no. 13, pp. 1580–1594, 1996.
- Y. Mishina, “Function of bone morphogenetic protein signaling during mouse development,” Frontiers in Bioscience, vol. 8, pp. d855–d869, 2003.
- T. Schlange, H.-H. Arnold, and T. Brand, “BMP2 is a positive regulator of Nodal signaling during left-right axis formation in the chicken embryo,” Development, vol. 129, no. 14, pp. 3421–3429, 2002.
- H. Zhang and A. Bradley, “Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development,” Development, vol. 122, no. 10, pp. 2977–2986, 1996.
- C. Kawamura, M. Kizaki, and Y. Ikeda, “Bone morphogenetic protein (BMP)-2 induces apoptosis in human myeloma cells,” Leukemia and Lymphoma, vol. 43, no. 3, pp. 635–639, 2002.
- M. Raida, J. H. Clement, K. Ameri, C. Han, R. D. Leek, and A. L. Harris, “Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death,” International Journal of Oncology, vol. 26, no. 6, pp. 1465–1470, 2005.
- Y. Du and H. Yip, “Effects of bone morphogenetic protein 2 on Id expression and neuroblastoma cell differentiation,” Differentiation, vol. 79, no. 2, pp. 84–92, 2010.
- J.-C. Guimond, M. Lévesque, P.-L. Michaud et al., “BMP-2 functions independently of SHH signaling and triggers cell condensation and apoptosis in regenerating axolotl limbs,” BMC Developmental Biology, vol. 10, article 15, 2010.
- C. C. Rider and B. Mulloy, “Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists,” Biochemical Journal, vol. 429, no. 1, pp. 1–12, 2010.
- D. B. Constam and E. J. Robertson, “Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases,” Journal of Cell Biology, vol. 144, no. 1, pp. 139–149, 1999.
- J. M. Wozney, “Bone morphogenetic proteins,” Progress in Growth Factor Research, vol. 1, no. 4, pp. 267–280, 1989.
- A. Hiyama, S. S. Gogate, S. Gajghate, J. Mochida, I. M. Shapiro, and M. V. Risbud, “BMP-2 and TGF-β stimulate expression of β1,3-glucuronosyl transferase 1 (GlcAT-1) in nucleus pulposus cells through AP1, TonEBP, and Sp1: role of MAPKs,” Journal of Bone and Mineral Research, vol. 25, no. 5, pp. 1179–1190, 2010.
- C. Alarcón, A.-I. Zaromytidou, Q. Xi et al., “Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways,” Cell, vol. 139, no. 4, pp. 757–769, 2009.
- J. Lemonnier, C. Ghayor, J. Guicheux, and J. Caverzasio, “Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation,” Journal of Biological Chemistry, vol. 279, no. 1, pp. 259–264, 2004.
- A. Moustakas and C.-H. Heldin, “From mono- to oligo-Smads: the heart of the matter in TGF-β signal transduction,” Genes and Development, vol. 16, no. 15, pp. 1867–1871, 2002.
- J. E. Felin, J. L. Mayo, T. J. Loos et al., “Nuclear variants of bone morphogenetic proteins,” BMC Cell Biology, vol. 11, no. 1, article 20, 2010.
- N. G. Copeland, N. A. Jenkins, and D. L. Court, “Recombineering: a powerful new tool for mouse functional genomics,” Nature Reviews Genetics, vol. 2, no. 10, pp. 769–779, 2001.
- S. Warming, N. Costantino, D. L. Court, N. A. Jenkins, and N. G. Copeland, “Simple and highly efficient BAC recombineering using galK selection,” Nucleic Acids Research, vol. 33, no. 4, article e36, 2005.
- M. Bunting, K. E. Bernstein, J. M. Greer, M. R. Capecchi, and K. R. Thomas, “Targeting genes for self-excision in the germ line,” Genes and Development, vol. 13, no. 12, pp. 1524–1528, 1999.
- S. H. George, M. Gertsenstein, K. Vintersten et al., “Developmental and adult phenotyping directly from mutant embryonic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 11, pp. 4455–4460, 2007.
- S. L. Mansour, K. R. Thomas, and M. R. Capecchi, “Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes,” Nature, vol. 336, no. 6197, pp. 348–352, 1988.
- V. E. Papaioannou and R. R. Behringer, Mouse Phenotypes—A Handbook of Mutation Analysis, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 2005.
- C. R. Hancock, J. J. Brault, R. W. Wiseman, R. L. Terjung, and R. A. Meyer, “31P-NMR observation of free ADP during fatiguing, repetitive contractions of murine skeletal muscle lacking AK1,” The American Journal of Physiology, vol. 288, no. 6, pp. C1298–C1304, 2005.
- C. R. Hancock, E. Janssen, and R. L. Terjung, “Skeletal muscle contractile performance and ADP accumulation in adenylate kinase-deficient mice,” The American Journal of Physiology, vol. 288, no. 6, pp. C1287–C1297, 2005.
- C. R. Hancock, E. Janssen, and R. L. Terjung, “Contraction-mediated phosphorylation of AMPK is lower in skeletal muscle of adenylate kinase-deficient mice,” Journal of Applied Physiology, vol. 100, no. 2, pp. 406–413, 2006.
- D. Kosk-Kosicka, “Calcium signaling protocols,” in Methods in Molecular Biology, D. G. Lambert, Ed., vol. 114, pp. 343–354, Springer, New York, NY, USA, 1999.
- F. Hillger, G. Herr, R. Rudolph, and E. Schwarz, “Biophysical comparison of BMP-2, ProBMP-2, and the free pro-peptide reveals stabilization of the pro-peptide by the mature growth factor,” Journal of Biological Chemistry, vol. 280, no. 15, pp. 14974–14980, 2005.
- B. Ohkawara, S. Iemura, P. ten Dijke, and N. Ueno, “Action range of BMP is defined by its N-terminal basic amino acid core,” Current Biology, vol. 12, no. 3, pp. 205–209, 2002.
- E. M. de Robertis, “Spemann's organizer and the self-regulation of embryonic fields,” Mechanisms of Development, vol. 126, no. 11-12, pp. 925–941, 2009.
- D. M. Maatouk, K.-S. Choi, C. M. Bouldin, and B. D. Harfe, “In the limb AER Bmp2 and Bmp4 are required for dorsal-ventral patterning and interdigital cell death but not limb outgrowth,” Developmental Biology, vol. 327, no. 2, pp. 516–523, 2009.
- B. Robert, “Bone morphogenetic protein signaling in limb outgrowth and patterning,” Development Growth and Differentiation, vol. 49, no. 6, pp. 455–468, 2007.
- A. Odermatt, K. Barton, V. K. Khanna et al., “The mutation of Pro789 to Leu reduces the activity of the fast-twitch skeletal muscle sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA1) and is associated with Brody disease,” Human Genetics, vol. 106, no. 5, pp. 482–491, 2000.
- A. Odermatt, P. E. Taschner, V. K. Khanna et al., “Mutations in the gene-encoding SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+ ATPase, are associated with Brody disease,” Nature Genetics, vol. 14, no. 2, pp. 191–194, 1996.
- A. A. Benders, J. H. Veerkamp, A. Oosterhof et al., “Ca2+ homeostasis in Brody's disease. A study in skeletal muscle and cultured muscle cells and the effects of dantrolene and verapamil,” Journal of Clinical Investigation, vol. 94, no. 2, pp. 741–748, 1994.
- I. A. Brody, “Muscle contracture induced by exercise. A syndrome attributable to decreased relaxing factor,” The New England Journal of Medicine, vol. 281, no. 4, pp. 187–192, 1969.
- Y. Zhang, J. Fujii, M. S. Phillips et al., “Characterization of cDNA and genomic DNA encoding SERCA1, the Ca2+-ATPase of human fast-twitch skeletal muscle sarcoplasmic reticulum, and its elimination as a candidate gene for Brody disease,” Genomics, vol. 30, no. 3, pp. 415–424, 1995.
- M. Endo, “Calcium-induced calcium release in skeletal muscle,” Physiological Reviews, vol. 89, no. 4, pp. 1153–1176, 2009.
- M. J. Betzenhauser and A. R. Marks, “Ryanodine receptor channelopathies,” Pflugers Archiv, vol. 460, no. 2, pp. 467–480, 2010.